Publications

Real-World Treatment and Retreatment Patterns and Outcomes in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Following Nivolumab Monotherapy in Second Line or Later in France: an I-O Optimise Analysis

AuthID
P-018-CZW

Author(s)

Justeau, G

Chouaid, C

Debieuvre, D

Audigier-Valette, C

Quantin, X

Léna, H

Bosquet, L

Girard, N

Schoemaker, MJ

Mella, M

Correia, BP

Rault, C

Daumont, MJ

Penrod, JR

Lee, AD

Pérol, M

Document Type

Article

Year published

2025

Published

in FRONTIERS IN ONCOLOGY, ISSN: 2234-943X

Volume: 15

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.3389/fonc.2025.1526931

Pubmed: 40052124

Scopus: 2-s2.0-86000360015

Wos: WOS:001437700100001

Source Identifiers

ISSN: 2234-943X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Real-World Treatment and Retreatment Patterns and Outcomes in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Following Nivolumab Monotherapy in Second Line or Later in France: an I-O Optimise Analysis

Useful Links

Get Help

Federated Authentication (Click on the image)

Real-World Treatment and Retreatment Patterns and Outcomes in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Following Nivolumab Monotherapy in Second Line or Later in France: an I-O Optimise Analysis

Useful Links

Get Help